AU1430099A - Use of galanthamine and galanthamine derivatives in the case of acute functionalbrain damage - Google Patents

Use of galanthamine and galanthamine derivatives in the case of acute functionalbrain damage

Info

Publication number
AU1430099A
AU1430099A AU14300/99A AU1430099A AU1430099A AU 1430099 A AU1430099 A AU 1430099A AU 14300/99 A AU14300/99 A AU 14300/99A AU 1430099 A AU1430099 A AU 1430099A AU 1430099 A AU1430099 A AU 1430099A
Authority
AU
Australia
Prior art keywords
galanthamine
functionalbrain
acute
damage
case
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU14300/99A
Inventor
Johannes Frohlich
Ulrich Jordis
Martin Alois Hermann Mucke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanochemia Pharmazeutika AG
Original Assignee
Sanochemia Pharmazeutika AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanochemia Pharmazeutika AG filed Critical Sanochemia Pharmazeutika AG
Publication of AU1430099A publication Critical patent/AU1430099A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU14300/99A 1998-12-01 1998-12-01 Use of galanthamine and galanthamine derivatives in the case of acute functionalbrain damage Abandoned AU1430099A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/AT1998/000291 WO2000032199A1 (en) 1998-12-01 1998-12-01 Use of galanthamine and galanthamine derivatives in the case of acute functional brain damage

Publications (1)

Publication Number Publication Date
AU1430099A true AU1430099A (en) 2000-06-19

Family

ID=3683792

Family Applications (1)

Application Number Title Priority Date Filing Date
AU14300/99A Abandoned AU1430099A (en) 1998-12-01 1998-12-01 Use of galanthamine and galanthamine derivatives in the case of acute functionalbrain damage

Country Status (2)

Country Link
AU (1) AU1430099A (en)
WO (1) WO2000032199A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT403803B (en) 1996-04-19 1998-05-25 Sanochemia Ltd NEW BENZAZEPINE DERIVATIVES, THESE MEDICINAL PRODUCTS AND THE USE THEREOF FOR THE PRODUCTION OF MEDICINAL PRODUCTS
ES2215885T3 (en) * 2000-03-31 2004-10-16 Sanochemia Pharmazeutika Aktiengesellschaft NEW DERIVATIVES AND ANALOGS OF GALANTAMINE.
AT414125B (en) * 2003-09-29 2006-09-15 Sanochemia Pharmazeutika Ag NEW DERIVATIVES OF 4A, 5,9,10,11,12-HEXAHYDRO-BENZOFURO (3A, 3,2) (2) BENZAZEPINE, PROCESS FOR THE PRODUCTION THEREOF AND THEIR USE FOR THE PRODUCTION OF MEDICAMENTS
AT500332B1 (en) * 2003-09-29 2008-09-15 Sanochemia Pharmazeutika Ag NEW DERIVATIVES OF (4AS, 8AS) -D5,6-4A, 5,9,10,11,12-HEXAHYDRO-11-METHYL-3-METHOXY-BENZOFURO (3A, 3,2-F) (2) BENZAZEPINE, PROCESS FOR THE PRODUCTION AND THEIR USE FOR THE PRODUCTION OF MEDICAMENTS
US20100168081A1 (en) * 2005-08-11 2010-07-01 Adriana Di Polo Galantamine as a neuroprotective drug for retinal ganglion cells
US20090253654A1 (en) 2005-09-22 2009-10-08 Galantos Pharma Gmbh Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment
ES2463715T3 (en) 2008-04-14 2014-05-29 Neurodyn Life Sciences Inc. Galantamine derivatives as prodrugs for the treatment of human brain diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3231571A1 (en) * 1982-08-25 1984-03-01 Naučno-issledovatel'skij institut po biologičeskim ispytanijam chimičeskich soedinenij, Staraja Kupavna, Moskovskaja oblast' Medicinal product as stimulator of nerve-muscle transmission, of the smooth muscles and of conduction in the peripheral and central nervous systems
JP2969359B2 (en) * 1989-01-13 1999-11-02 武田薬品工業株式会社 Cyclic amine compounds
DE4010079A1 (en) * 1990-03-29 1991-10-02 Lohmann Therapie Syst Lts PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF ALCOHOLISM
JP2660086B2 (en) * 1990-07-03 1997-10-08 明治製菓株式会社 Agent for improving brain and cardiac dysfunction
AT402691B (en) * 1996-01-26 1997-07-25 Sanochemia Ltd USE OF GALANTHAMINE FOR PRODUCING MEDICINAL PRODUCTS FOR TREATING TRISOMY 21 OR RELATED TRISOMY SYNDROME
AT403803B (en) * 1996-04-19 1998-05-25 Sanochemia Ltd NEW BENZAZEPINE DERIVATIVES, THESE MEDICINAL PRODUCTS AND THE USE THEREOF FOR THE PRODUCTION OF MEDICINAL PRODUCTS

Also Published As

Publication number Publication date
WO2000032199A1 (en) 2000-06-08

Similar Documents

Publication Publication Date Title
HU9903361D0 (en) Filter-device with collecting-vessel and with heating-device
AU5872899A (en) Plug and plug set for use in wellbore
AU4208799A (en) Interleukins-21 and 22
HK1023343A1 (en) Pyrazolopyrimidines and pyrazolotriazines
HUP0101320A3 (en) Benzo- and pyridobenzoxepine and -benzazepine derivatives and use thereof
AU4161899A (en) Radiotherapeutical device and use thereof
AU2875297A (en) N-(4-aryl-thiazol-2-yl)-sulphonamide derivatives and their use
AU6931898A (en) Procedure of aligning objects in a field and application of the procedure
AU1174900A (en) Avidin derivatives and uses thereof
HUP9904367A3 (en) Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect
AU1037900A (en) Magnetic bearing and its use
HUP0105411A3 (en) Palladium-substituted bacteriochlorophyll derivatives and use thereof
HUP0103636A3 (en) 2-methyl-thieno-benzodiazepine formulation and its use
AU2464197A (en) Triazine derivatives and their use
AU2841801A (en) Triazolotriazinones and the use thereof
AU5923998A (en) 2-benzoylamino-3-phenylpropenamide derivatives and methods of using the same
HK1041200A1 (en) Cyclopentanone derivatives and their use
AU1430099A (en) Use of galanthamine and galanthamine derivatives in the case of acute functionalbrain damage
AU3150399A (en) Method and arrangement in connection with double spooling
IL123535A0 (en) Benzoxazindione derivatives and their use
AU2405397A (en) Thienopyridine derivatives and their use
AU2669201A (en) Taccalonolides and their use
AU2980799A (en) Lectomedin materials and methods
GB9807586D0 (en) Enzymes and their use
AU3432900A (en) Colouring agent and the use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase